Atrial fibrillation: a risk factor for unfavourable outcome in COVID-19? A case report

Atrial fibrillation: a risk factor for unfavourable outcome in COVID-19? A case report

Abstract Background Fulminant cardiac involvement in COVID-19 patients has been reported; the underlying suspected mechanisms include myocarditis, arrhythmia, and cardiac tamponade. In parallel, atrial fibrillation is common in the elderly population which is at particularly high risk for COVID-19 m...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:European heart journal : case reports 2020-10, Vol.4 (FI1), p.1-6
Hauptverfasser: Schnaubelt, Sebastian, Breyer, Marie-Kathrin, Siller-Matula, Jolanta, Domanovits, Hans
Format: Artikel
Sprache:eng
Schlagworte:
Case Reports
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 6
container_issue FI1
container_start_page 1
container_title European heart journal : case reports
container_volume 4
creator Schnaubelt, Sebastian
Breyer, Marie-Kathrin
Siller-Matula, Jolanta
Domanovits, Hans
description Abstract Background Fulminant cardiac involvement in COVID-19 patients has been reported; the underlying suspected mechanisms include myocarditis, arrhythmia, and cardiac tamponade. In parallel, atrial fibrillation is common in the elderly population which is at particularly high risk for COVID-19 morbidity and mortality. Case summary A 72-year-old male SARS-CoV2-positive patient was admitted to the intensive care unit due to delirium and acute respiratory failure. Atrial fibrillation known from history was exacerbated, and made complex rate and rhythm control necessary. Progressive heart failure with haemodynamic deterioration and acute kidney injury with the need for continuous renal replacement therapy were further aggravated by pericardial tamponade. Discussion Treatment of acute heart failure in COVID-19 patients with a cytokine storm complicated by tachycardic atrial fibrillation should include adequate rate or rhythm control, and potentially immunomodulation.
doi_str_mv 10.1093/ehjcr/ytaa166
format Article
fullrecord <record><control><sourceid>oup_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7337643</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><oup_id>10.1093/ehjcr/ytaa166</oup_id><sourcerecordid>10.1093/ehjcr/ytaa166</sourcerecordid><originalsourceid>FETCH-LOGICAL-c387t-f6935f43891162ecfc497392b485d8f2115baec0cad9a7b7a9887cf9b946770f3</originalsourceid><addsrcrecordid>eNqFkD1PwzAQhi0EolXpyIo8soTacRLHDKCqfFWq1AW6WhfXpi5pHDlOpf57Ai2oTAzWWbrn3js9CF1SckOJYCO9Wis_2gUAmmUnqB-nNIliSsXp0b-Hhk2zJoTEhImMs3PUY4zkgiRpHy3GwVsosbGFt2UJwbrqFgP2tvnABlRwHpvutZWBrWs9FKXGrg3KbTS2FZ7MF9OHiIp7PMYKGo29rp0PF-jMQNno4aEO0NvT4-vkJZrNn6eT8SxSLOchMplgqUlYLijNYq2MSgRnIi6SPF3mprs-LUAromApgBccRJ5zZUQhkoxzYtgA3e1z67bY6KXSVfBQytrbDfiddGDl305lV_LdbSVnjGcJ6wKifYDyrmm8Nr-zlMgvx_LbsTw47vir44W_9I_RDrjeA66t_8n6BEP2iCw</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Atrial fibrillation: a risk factor for unfavourable outcome in COVID-19? A case report</title><source>Oxford Journals Open Access Collection</source><source>DOAJ Directory of Open Access Journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central</source><creator>Schnaubelt, Sebastian ; Breyer, Marie-Kathrin ; Siller-Matula, Jolanta ; Domanovits, Hans</creator><creatorcontrib>Schnaubelt, Sebastian ; Breyer, Marie-Kathrin ; Siller-Matula, Jolanta ; Domanovits, Hans</creatorcontrib><description>Abstract Background Fulminant cardiac involvement in COVID-19 patients has been reported; the underlying suspected mechanisms include myocarditis, arrhythmia, and cardiac tamponade. In parallel, atrial fibrillation is common in the elderly population which is at particularly high risk for COVID-19 morbidity and mortality. Case summary A 72-year-old male SARS-CoV2-positive patient was admitted to the intensive care unit due to delirium and acute respiratory failure. Atrial fibrillation known from history was exacerbated, and made complex rate and rhythm control necessary. Progressive heart failure with haemodynamic deterioration and acute kidney injury with the need for continuous renal replacement therapy were further aggravated by pericardial tamponade. Discussion Treatment of acute heart failure in COVID-19 patients with a cytokine storm complicated by tachycardic atrial fibrillation should include adequate rate or rhythm control, and potentially immunomodulation.</description><identifier>ISSN: 2514-2119</identifier><identifier>EISSN: 2514-2119</identifier><identifier>DOI: 10.1093/ehjcr/ytaa166</identifier><identifier>PMID: 33089045</identifier><language>eng</language><publisher>England: Oxford University Press</publisher><subject>Case Reports</subject><ispartof>European heart journal : case reports, 2020-10, Vol.4 (FI1), p.1-6</ispartof><rights>The Author(s) 2020. Published by Oxford University Press on behalf of the European Society of Cardiology. 2020</rights><rights>The Author(s) 2020. Published by Oxford University Press on behalf of the European Society of Cardiology.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c387t-f6935f43891162ecfc497392b485d8f2115baec0cad9a7b7a9887cf9b946770f3</citedby><cites>FETCH-LOGICAL-c387t-f6935f43891162ecfc497392b485d8f2115baec0cad9a7b7a9887cf9b946770f3</cites><orcidid>0000-0001-6041-1635 ; 0000-0003-0057-8200 ; 0000-0003-2086-8483</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7337643/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7337643/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,860,881,1598,27901,27902,53766,53768</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/33089045$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Schnaubelt, Sebastian</creatorcontrib><creatorcontrib>Breyer, Marie-Kathrin</creatorcontrib><creatorcontrib>Siller-Matula, Jolanta</creatorcontrib><creatorcontrib>Domanovits, Hans</creatorcontrib><title>Atrial fibrillation: a risk factor for unfavourable outcome in COVID-19? A case report</title><title>European heart journal : case reports</title><addtitle>Eur Heart J Case Rep</addtitle><description>Abstract Background Fulminant cardiac involvement in COVID-19 patients has been reported; the underlying suspected mechanisms include myocarditis, arrhythmia, and cardiac tamponade. In parallel, atrial fibrillation is common in the elderly population which is at particularly high risk for COVID-19 morbidity and mortality. Case summary A 72-year-old male SARS-CoV2-positive patient was admitted to the intensive care unit due to delirium and acute respiratory failure. Atrial fibrillation known from history was exacerbated, and made complex rate and rhythm control necessary. Progressive heart failure with haemodynamic deterioration and acute kidney injury with the need for continuous renal replacement therapy were further aggravated by pericardial tamponade. Discussion Treatment of acute heart failure in COVID-19 patients with a cytokine storm complicated by tachycardic atrial fibrillation should include adequate rate or rhythm control, and potentially immunomodulation.</description><subject>Case Reports</subject><issn>2514-2119</issn><issn>2514-2119</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>TOX</sourceid><recordid>eNqFkD1PwzAQhi0EolXpyIo8soTacRLHDKCqfFWq1AW6WhfXpi5pHDlOpf57Ai2oTAzWWbrn3js9CF1SckOJYCO9Wis_2gUAmmUnqB-nNIliSsXp0b-Hhk2zJoTEhImMs3PUY4zkgiRpHy3GwVsosbGFt2UJwbrqFgP2tvnABlRwHpvutZWBrWs9FKXGrg3KbTS2FZ7MF9OHiIp7PMYKGo29rp0PF-jMQNno4aEO0NvT4-vkJZrNn6eT8SxSLOchMplgqUlYLijNYq2MSgRnIi6SPF3mprs-LUAromApgBccRJ5zZUQhkoxzYtgA3e1z67bY6KXSVfBQytrbDfiddGDl305lV_LdbSVnjGcJ6wKifYDyrmm8Nr-zlMgvx_LbsTw47vir44W_9I_RDrjeA66t_8n6BEP2iCw</recordid><startdate>20201001</startdate><enddate>20201001</enddate><creator>Schnaubelt, Sebastian</creator><creator>Breyer, Marie-Kathrin</creator><creator>Siller-Matula, Jolanta</creator><creator>Domanovits, Hans</creator><general>Oxford University Press</general><scope>TOX</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0001-6041-1635</orcidid><orcidid>https://orcid.org/0000-0003-0057-8200</orcidid><orcidid>https://orcid.org/0000-0003-2086-8483</orcidid></search><sort><creationdate>20201001</creationdate><title>Atrial fibrillation: a risk factor for unfavourable outcome in COVID-19? A case report</title><author>Schnaubelt, Sebastian ; Breyer, Marie-Kathrin ; Siller-Matula, Jolanta ; Domanovits, Hans</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c387t-f6935f43891162ecfc497392b485d8f2115baec0cad9a7b7a9887cf9b946770f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Case Reports</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Schnaubelt, Sebastian</creatorcontrib><creatorcontrib>Breyer, Marie-Kathrin</creatorcontrib><creatorcontrib>Siller-Matula, Jolanta</creatorcontrib><creatorcontrib>Domanovits, Hans</creatorcontrib><collection>Oxford Journals Open Access Collection</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>European heart journal : case reports</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Schnaubelt, Sebastian</au><au>Breyer, Marie-Kathrin</au><au>Siller-Matula, Jolanta</au><au>Domanovits, Hans</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Atrial fibrillation: a risk factor for unfavourable outcome in COVID-19? A case report</atitle><jtitle>European heart journal : case reports</jtitle><addtitle>Eur Heart J Case Rep</addtitle><date>2020-10-01</date><risdate>2020</risdate><volume>4</volume><issue>FI1</issue><spage>1</spage><epage>6</epage><pages>1-6</pages><issn>2514-2119</issn><eissn>2514-2119</eissn><abstract>Abstract Background Fulminant cardiac involvement in COVID-19 patients has been reported; the underlying suspected mechanisms include myocarditis, arrhythmia, and cardiac tamponade. In parallel, atrial fibrillation is common in the elderly population which is at particularly high risk for COVID-19 morbidity and mortality. Case summary A 72-year-old male SARS-CoV2-positive patient was admitted to the intensive care unit due to delirium and acute respiratory failure. Atrial fibrillation known from history was exacerbated, and made complex rate and rhythm control necessary. Progressive heart failure with haemodynamic deterioration and acute kidney injury with the need for continuous renal replacement therapy were further aggravated by pericardial tamponade. Discussion Treatment of acute heart failure in COVID-19 patients with a cytokine storm complicated by tachycardic atrial fibrillation should include adequate rate or rhythm control, and potentially immunomodulation.</abstract><cop>England</cop><pub>Oxford University Press</pub><pmid>33089045</pmid><doi>10.1093/ehjcr/ytaa166</doi><tpages>6</tpages><orcidid>https://orcid.org/0000-0001-6041-1635</orcidid><orcidid>https://orcid.org/0000-0003-0057-8200</orcidid><orcidid>https://orcid.org/0000-0003-2086-8483</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2514-2119
ispartof European heart journal : case reports, 2020-10, Vol.4 (FI1), p.1-6
issn 2514-2119
2514-2119
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7337643
source Oxford Journals Open Access Collection; DOAJ Directory of Open Access Journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central
subjects Case Reports
title Atrial fibrillation: a risk factor for unfavourable outcome in COVID-19? A case report
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-06T13%3A11%3A21IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-oup_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Atrial%20fibrillation:%20a%20risk%20factor%20for%20unfavourable%20outcome%20in%20COVID-19?%20A%20case%20report&rft.jtitle=European%20heart%20journal%20:%20case%20reports&rft.au=Schnaubelt,%20Sebastian&rft.date=2020-10-01&rft.volume=4&rft.issue=FI1&rft.spage=1&rft.epage=6&rft.pages=1-6&rft.issn=2514-2119&rft.eissn=2514-2119&rft_id=info:doi/10.1093/ehjcr/ytaa166&rft_dat=%3Coup_pubme%3E10.1093/ehjcr/ytaa166%3C/oup_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/33089045&rft_oup_id=10.1093/ehjcr/ytaa166&rfr_iscdi=true